Condition
Hernia Incisional Ventral
Total Trials
4
Recruiting
1
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 4 (1)
Trial Status
Not Yet Recruiting1
Completed1
Active Not Recruiting1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05094089Active Not Recruiting
Assessment of GORE® SYNECOR Biomaterial in Focused Patient Populations and Long-Term Application
NCT07295379Not Yet RecruitingPrimary
LIQUIBAND FIX8® for Ventral Incisional Hernia
NCT07220382Phase 4Recruiting
Preoperative BOTOX® Injection for Large Ventral Hernia Repair
NCT04430816Not ApplicableCompletedPrimary
Management Of Large Incisional Hernia, Double Mesh Modification Of Chevrel's Technique Versus On Lay Mesh Hernioplasty
Showing all 4 trials